Gilead Sciences (GILD) Inventory Average (2009 - 2026)

Gilead Sciences has reported Inventory Average for 18 years, with the latest figure at $1.8 billion in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average rose 6.31% year-over-year to $1.8 billion; the trailing twelve-month figure through Mar 2026 stood at $1.8 billion (up 6.31% YoY), and the FY2025 full-year result was $1.7 billion, changed 0.37% from the prior year.
• Inventory Average for Q1 2026 stood at $1.8 billion, up from $1.8 billion in the prior quarter.
• The five-year high for Inventory Average was $1.9 billion in Q3 2024, with the low at $1.5 billion in Q3 2022.
• Historically, Inventory Average has averaged $1.7 billion across 5 years, with a median of $1.7 billion in 2025.
• Annual changes were most pronounced in 2022 — Inventory Average dropped 16.19% — and 2024, when it grew 20.88%.
• Gilead Sciences' Inventory Average stood at $1.5 billion in 2022, then increased by 16.16% to $1.7 billion in 2023, then grew by 3.74% to $1.8 billion in 2024, then fell by 0.56% to $1.8 billion in 2025, then gained by 3.62% to $1.8 billion in 2026.
• The last three Inventory Average figures came in at $1.8 billion (Q1 2026), $1.8 billion (Q4 2025), and $1.8 billion (Q3 2025), per Business Quant data.